Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Testosterone increases hamster hair growth; cyproterone acetate reduces it.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

Most women with excess hair growth need only a clinical evaluation and minimal tests unless they show signs of virilism.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Environmental factors like smoking, UV exposure, and poor diet contribute to hair loss and graying, and lifestyle changes can help manage it.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

Interest in new and personalized treatments for hair loss is growing.

Ketoconazole shampoo may help reduce hair loss and improve hair health.

PCOS is a common condition in women that can lead to infertility and other health issues, and it's diagnosed by specific criteria with various treatment options available.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Testosterone stimulates growth in intermediate hair follicles, but this can be blocked by cyproterone acetate.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Male pattern baldness is mainly caused by a hormone called dihydrotestosterone (DHT), and drugs that can block this hormone might help prevent hair loss.

COVID-19 may worsen hair loss, but treatments like minoxidil can help.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Malassezia yeast linked to hair loss; ketoconazole helps treat it.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

Licorice extract shampoo with surfactants is the best for hair growth.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.